Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Major Depression and Pain
NCT00036335Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) and pain comparing Duloxetine with Placebo (2 arms). Primary endpoint: 17-item Hamilton Rating Scale for Depression at 9 weeks. Started Mar 2002; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)pain
Beyond the preview
Go deeper on NCT00036335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036335.